Scientists are using AI and physics-based simulations together to design new peptides that will kill previously ...

A prototype cell partly capable of replicating itself has been created using 36 existing bacterial genes, but it's not really ...

It is barely the second quarter of the year, yet the Kenyan healthcare regulatory landscape is being redrawn. Two documents released in 2026 will be major determinants of how pharmacies, clinics, ...

A team of researchers at the University of Warwick and Monash University has solved a puzzle that has stumped drug developers ...

The U.S. Food and Drug Administration on Monday selected Eli Lilly , Regeneron and five ​other companies for a pilot program ...

FDA names companies domestic drug manufacturing pilot participants to enhance early regulatory engagement and streamline review processes.

A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...

President Donald Trump’s pick to serve as the next IT lead for the Department of Veterans Affairs told lawmakers this week that the agency’s technology operations are “a target-rich environment” for ...

President Donald Trump’s choice for acting director of national intelligence, Bill Pulte, has proved controversial. Pulte’s lack of background in national security matters has sparked resistance from ...